120
Participants
Start Date
November 3, 2021
Primary Completion Date
July 31, 2025
Study Completion Date
August 31, 2025
SHAPE measurement using the ultrasound contrast agent Sonazoid (perfluorobutane microbubbles)
The ultrasound contrast agent will be infused thorough an IV line and SHAPE ultrasound imaging and data acquisition will be performed with a Logiq E10 (GE Medical Systems, Waukesha, WI) ultrasound scanner.
SHAPE measurement using the ultrasound contrast agent Lumason (sulfur hexafluoride lipid-type A microspheres)
The ultrasound contrast agent will be infused thorough an IV line and SHAPE ultrasound imaging and data acquisition will be performed with a Logiq E10 (GE Medical Systems, Waukesha, WI) ultrasound scanner.
RECRUITING
The Children's Hospital of Philadelphia, Philadelphia
Children's Hospital of Philadelphia
OTHER
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
Thomas Jefferson University
OTHER